USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Coopervision International Limited

USPTO PatentsView assignee record - 142 granted patents across 37 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02C (SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

142

Total patents granted

CPC technology areas

17.2

Avg claims per patent

+22%

5-year filing velocity

The verdict

Coopervision holds 142 US patents across 37 technology areas, rank #2,719 of 50,000 tracked assignees.

#2,719
of 50,000 US assignees by volume: Top 1%
by Innovation Score (67.0/100): 17.2
avg claims per patent: +22%
filing velocity, last 5 yrs

Portfolio overview

Coopervision International Limited has been granted 142 US utility patents between 2015 and 2025, placing Coopervision International Limited at rank #2,719 across all assignees tracked by PlainPatent. This portfolio spans 37 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in G02C (SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES). As a Foreign Corporation, Coopervision International Limited is one of the more focused assignees in the PatentsView dataset. By volume, Coopervision sits between Taiwan FU Hsing Industrial Co., Ltd. (143 patents, rank #2,715) and Harting Electric Gmbh & Co. KG (142 patents, rank #2,723) - the closest US assignees by grant volume. The composite Innovation Score of 67.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 78 grants, compared with 64 in the 2015–2019 window, a +22% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Coopervision International Limited's 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 37 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Coopervision International Limited against peers pursuing similar technology classes.

Taiwan FU Hsing I…

143
Teleflex Medical…

143
Tele Tracking

143
ZOLL Circulation

143
Cohere

142
DTS

142
Fondazione Istitu…

142
Harting Electric…

142
Coopervision Inte… ◀

142

What this shows Coopervision holds 142 patents at rank #2,719, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Coopervision

By rank, the assignees closest to #2,719 in granted patent volume.

Leaders in G02C (Spectacles)

Other assignees with the most granted patents in Coopervision's primary technology class.

Coopervision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Coopervision International Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	7.0%
2016	18	12.7%
2017	11	7.7%
2018	14	9.9%
2019	11	7.7%
2020	3	2.1%
2021	6	4.2%
2022	8	5.6%
2023	18	12.7%
2024	28	19.7%
2025	15	10.6%

Which technologies does Coopervision International Limited patent most?

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 70

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 63

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 58

A45C - PURSES; LUGGAGE; HAND CARRIED BAGS 38

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 37

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 21

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 21

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 20

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 19

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 18

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 11

G02F - OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS 6

C08J - WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H 5

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 5

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 5

Top 15 of 37 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#2,719

Across all tracked assignees

Innovation Score

67.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Coopervision International Limited hold?

Coopervision International Limited holds 142 US granted patents filed between 2015 and 2025, spanning 37 technology areas.

What is Coopervision International Limited's Innovation Score?

Coopervision International Limited has an Innovation Score of 67.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Coopervision International Limited focus on?

Coopervision International Limited's top technology area is G02C (SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES) with 70 patents. The company has filed patents in 37 CPC subclasses total.

Is Coopervision International Limited's patent filing rate increasing or decreasing?

Coopervision International Limited's recent filing velocity is +22% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Coopervision International Limited's patents?

Coopervision International Limited's patents average 17.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Coopervision International Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Coopervision's 142 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Coopervision ranks #2,719 of 50,000. Top 50 holders
Most of this portfolio concentrates in G02C - see who else leads that technology area. G02C leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.